← All Sponsors
SPONSOR

UMC Utrecht

Total Trials
11
Recruiting
11
Phases
Phase 2, Phase 3, Phase 1

UMC Utrecht is a clinical research sponsor with 11 registered studies on ClinicalTrials.gov, of which 11 are actively recruiting participants. Research covers conditions including Fahr Disease, Fahr Syndrome, Primary Familial Brain Calcification, Respiratory Tract Diseases.

The trial portfolio spans Phase 2, Phase 3, Phase 1 studies, reflecting a pipeline that may include early-stage safety evaluations, mid-stage efficacy assessments, and large-scale confirmatory trials. All studies listed here are sourced directly from ClinicalTrials.gov and updated daily.

Frequently Asked Questions — UMC Utrecht

How many clinical trials has UMC Utrecht sponsored?
ClinicalMetric currently tracks 11 clinical trials sponsored by UMC Utrecht, of which 11 are actively recruiting participants. These trials cover conditions including Fahr Disease, Fahr Syndrome, Primary Familial Brain Calcification. Trial counts are updated daily from ClinicalTrials.gov and reflect currently registered studies.
What therapeutic areas does UMC Utrecht research focus on?
UMC Utrecht clinical trials span Fahr Disease, Fahr Syndrome, Primary Familial Brain Calcification, Respiratory Tract Diseases, Influenza (Pandemic), and additional conditions. The research pipeline includes Phase 2, Phase 3, Phase 1 trials, reflecting work from early-stage safety evaluation through large-scale efficacy studies.
How do I participate in a UMC Utrecht clinical trial?
To participate in a UMC Utrecht trial, review the active studies listed on this page, check each trial's specific eligibility criteria on ClinicalTrials.gov, and contact the trial site directly—not the sponsor's headquarters. Trial sites are academic medical centers, hospitals, or specialized research clinics. Your physician can facilitate a referral. ClinicalMetric lists all UMC Utrecht trials with current recruitment status updated daily.

Clinical Trials by UMC Utrecht

NCT05662111 Phase 2
Recruiting

Treatment of Ectopic Calcification in Fahr's Disease or Syndrome

Fahr Disease
NCT02735707 Phase 3
Recruiting

Randomized, Embedded, Multifactorial Adaptive Platform Trial for Community- Acquired Pneumonia

Respiratory Tract Diseases
NCT07482124
Recruiting

Multicenter Registry of Patients With Subarachnoid Hemorrhage

Subarachnoid Hemorrhage, Spontaneous
NCT06431425
Recruiting

The Electronic Cardiovascular Genetics (eCG) Clinic for Presymptomatic Genetic Counselling

Inherited Cardiac Disease
NCT06925308
Recruiting

Course of Face-to-face Interactions in Adults With Autism

Autism Spectrum Disorder (ASD)
NCT06124248
Recruiting

Effectiveness of the RISE Intervention

Sedentary Behaviour
NCT04075305
Recruiting

The MOMENTUM Study: The Multiple Outcome Evaluation of Radiation Therapy Using the MR-Linac Study

Oncology
NCT04881487
Recruiting

Additional Treatment for Isolated Local Pancreatic Cancer Recurrence Using Stereotactic Body Radiation Therapy

Recurrent Pancreatic Ductal Adenocarcinoma
NCT06524570 Phase 1
Recruiting

Treatment of Cancer With Immune Checkpoint Inhibition Therapy Boosted by High Intensity Focused Ultrasound Histotripsy

Cancer
NCT06314503
Recruiting

First-in-human Study to Examine Safety of a New Peritoneal Dialysis Device (WEAKID) in End-stage Kidney Disease Patients

Renal Insufficiency, Chronic
NCT04364334
Recruiting

Knee Registry (Knieregister)

Knee Pathology
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: November 2026  ·  Data Methodology